ETELCALCETIDE - 7 Annonces
401120 Matières premièresSignalez un abus
Tuesday 26 August 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands, which...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
401000 Pro / B2BSignalez un abus
Friday 25 July 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands,...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401120 Matières premièresSignalez un abus
Tuesday 22 July 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands, which...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
401000 MédicalSignalez un abus
Thursday 17 July 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands,...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401000 Pro / B2BSignalez un abus
Friday 11 July 2025
依替卡塞肽是一种新型拟钙剂 （CalcimeticAgent），专为通过静脉给药接受血液透析治疗的慢性肾病 （CKD） 患者而开发。AMG416 与甲状旁腺结合并激活钙敏感受体，导致甲状旁腺激素 （PTH） 水平降低。FDA 批准新型拟钙剂维拉西坦用于治疗成年血液透析患者的继发性甲状旁腺功能亢进症，这是 12 年来第一种获批用于治疗透析患者继发性甲状旁腺功能亢进症的药物。接受维拉西坦治疗的 中度至重度甲状旁腺功能亢进症血液透析患者的 PTH 水平显著降低。 品牌： Soarwin CAS号：1262780-97-1 分子式： C38H73N21O10S2 密度：1...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401120 MédicalSignalez un abus
Tuesday 01 July 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands, which...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
401120 MédicalSignalez un abus
Tuesday 24 June 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands, which...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
Aide sur la recherche
- Les guillemets permettent des recherches sur des phrases exactes, par exemple "chat noir".
- Les moins éliminent les mots, par exemple pour avoir chien sans chat siamois : chien -"chat siamois".
